DAYU BIOLOGICAL
871970
WuHan Hvsen Biotechnology
300871
Ningxia Xiaoming Agriculture&Animal Husbandry
300967
4
Jiangsu LiXing General Steel Ball
300421
5
Guangdong Kitech New Material Holding
300995
US Stock MarketDetailed Quotes
ATHA Athira
- 0.335
- -0.005-1.38%
Close Mar 25 16:00 ET
- 0.335
- 0.0000.00%
Post 20:01 ET
13.09MMarket Cap-0.13P/E (TTM)
0.350High0.325Low129.64KVolume0.330Open0.340Pre Close43.44KTurnover0.47%Turnover RatioLossP/E (Static)39.04MShares3.67052wk High0.29P/B9.24MFloat Cap0.30152wk Low--Dividend TTM27.56MShs Float34.790Historical High--Div YieldTTM7.27%Amplitude0.301Historical Low0.335Avg Price1Lot Size
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Athira Stock Forum
$Roth CH Acquisition V Co(Delisted) (ROCL.US)$ Ticker change tomorr...
This is their balance sheet as of SEP 2024, in this it shows stock holders equity 57Mil, which is now down to 25M(Market cap), so the liability is 25+28=53Mil which is still less than the cash they hold 69Mil...
someone new something 👀
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association's 35th International Symposium on ALS/MND
Friday, 6th December at 5:30 pm
BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today presented preclinical data highli...
No comment yet